STAT+: Pharmalittle: More biotechs are betting on obesity; Pfizer RSV vaccine faces hurdles in low-income countries
A growing number of biotechs are betting on novel mechanisms to treat obesity, hoping that their products will have a unique edge.
Good morning, everyone, and nice to see you again after a week-long respite in which we toured historical sites, gazed at
